Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-009161

Options or other derivatives

  • President and CEO acquired 1,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shukla Sanjay · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-09 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +1,500,000 1,500,000 D
Loading xslF345X05/ownership.xml…